Grassley-Wyden drug price bill attacks rebates, includes inflation caps

A revised version of bipartisan Senate drug pricing legislation would pass Medicare Part D rebates to beneficiaries, rather than drug plans.

The Congressional Budget Office estimates the Prescription Drug Pricing Reduction Act, co-sponsored by Sens.

Read the full 353 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE